Detalhe da pesquisa
1.
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Nat Med
; 29(10): 2473-2480, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37709999
2.
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
Focus (Am Psychiatr Publ)
; 21(3): 315-328, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404971
3.
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial.
J Affect Disord
; 314: 59-67, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809678
4.
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Nat Med
; 27(6): 1025-1033, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972795
5.
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary.
Am J Psychiatry
; 181(1): 76-77, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38161307
6.
Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.
Am J Psychiatry
; 181(1): 74-75, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38161295
7.
An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120.
AIDS Res Hum Retroviruses
; 20(8): 836-45, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15320988